DURHAM, NC -- (MARKET WIRE) -- May 04, 2007 -- Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that it will be participating in a Breakout Session entitled "Adult Stem Cells: Current Medical and Business Challenges and Opportunities" at the 2007 BIO International Convention. In addition, the company will be presenting at the BIO Business Forum during the conference. The conference is taking place at the Boston Convention & Exhibition Center.
